Logo

Hologic to Acquire Mobidiag for ~ $795M

Share this

Hologic to Acquire Mobidiag for ~ $795M

Shots:

  • Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21
  • The acquisition will accelerate Hologic's global footprints by enabling it to expand into the large- fast-growing acute care adjacency with a near-patient testing solution that offers ease of use- multiplex capability and rapid turnaround time
  • Mobidiag offers a broad range of tests and automated platforms including Amplidiag and Novodiag. Additionally- Hologic plans to invest in assay development to promote the growth of the Novodiag platform

  Ref: BusinessWire | Image: Medical Product Outsourcing

Click here to­ read the full press release 

Tags


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions